Pharma major Biocon Ltd is betting on a wave of biosimilar launches, expanded insulin capacity, and deeper US market penetration to drive growth over the next 12–18 months, according to MD & CEO of ...

Biocon Limited on Tuesday received USFDA approval for its generic version of Liraglutide Injection (18 mg/3 mL), a GLP-1 weight management drug sold under the brand name Saxenda, marking the company’s ...

Biocon has announced several corporate actions, including press releases, disclosures under SEBI regulations, and qualified institutions placements. The company has announced final dividends in the ...

Feb 16 (Reuters) - Biocon (BION.NS), opens new tab is aiming for high-double-digit percentage revenue growth as the Indian pharmaceutical firm prepares to launch generic versions of weight-loss drugs ...

Stay on top of the latest tech trends and biggest startup news.

Earnings call Biocon reported 9% YoY revenue growth in Q3 FY26, with biosimilars and generics offsetting CRDMO softness. Core EBITDA rose 21% YoY to INR 1,221 crore with a 29% margin, driven by ...

Which bladder control supplements are best? Involuntary urination is a scary condition for most people, and specific medical issues, stress or aging can lead to incontinence. But there are steps you ...

Mumbai: Solid YoY performance backed Biocon’s Q3 FY26 results, with revenue from operations increasing to Rupees 4,173 crore from Rupees 3,821 crore in Q3 FY25. The reported net profit jumped ...

Regulator recommends durvalumab as first perioperative IO option for muscle‑invasive disease AstraZeneca has received a positive recommendation from the National Institute for Health and Care ...

LONDON, UK / ACCESS Newswire / February 11, 2026 / The global intraoral scanner market is poised for strong and sustained growth through 2035, driven by the rapid adoption of digital dentistry ...

IT rout drags Indian markets; sector on track for worst month in 23 years on AI fears Indian equity benchmarks tumbled on Tuesday, dragged by information technology stocks which are on course for ...

Rachel works as a CRNA where she provides anesthesia care across the lifespan, including pediatric anesthesia, with a primary focus on orthopedic anesthesia. She is also an Assistant Professor at the ...